Patents-Review.com
ClassID:

108955 ⎘

C12N9/2465 - CPC Classification

Classification description:

Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)

Recent Application in this class:
#1
20260146242
2026-05-28

ALPHA-GALACTOSIDASE PROTEIN FOR ENZYME REPLACEMENT THERAPY (ERT) AND METHODS OF USE

 #2
20260139270
2026-05-21

HYBRID AAV VECTOR ENHANCING TRANSGENE EXPRESSION IN THE LIVER

 #3
20260109677
2026-04-23

COMPOUNDS, DEVICES, AND USES THEREOF

 #4
20260049297
2026-02-19

STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF

 #5
20260015600
2026-01-15

Highly Potent Acid Alpha-Glucosidase With Enhanced Carbohydrates

 #6
20250257105
2025-08-14

ICAM-1 TARGETED FUSION ENZYMES

 #7
20250207118
2025-06-26

HUMAN ALPHA-GALACTOSIDASE VARIANTS

 #8
20250188433
2025-06-12

COMPOSITIONS AND METHODS FOR INTERNALIZING ENZYMES

 #9
20250188428
2025-06-12

NOVEL IN VITRO AND IN VIVO ENRICHMENT STRATEGY TARGETING LYMPHOCYTES DERIVED FROM VECTOR TRANSDUCED HSCS FOR THERAPY OF DISORDERS

 #10
20250179460
2025-06-05

HUMAN ALPHA-GALACTOSIDASE VARIANTS

 #11
20250152735
2025-05-15

Lipid Nanoparticle Compositions and Methods for mRNA Delivery

 #12
20250108126
2025-04-03

Lipid Nanoparticle Compositions and Methods for mRNA Delivery

 #13
20250066812
2025-02-27

RECOMBINANT AAV FOR THE GENE THERAPY OF FABRY DISEASE

 #14
20250041388
2025-02-06

Human alpha-galactosidase variants

 #15
20250041194
2025-02-06

COMPOSITION COMPRISING GALACTINOL AND USE THEREOF

 #16
20240417427
2024-12-19

Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances

 #17
20240409650
2024-12-12

METHODS AND COMPOSITIONS FOR INCREASING N-ACETYLGLUCOSAMINIDASE ACTIVITY IN THE CNS

 #18
20240360431
2024-10-31

ENGINEERED ALPHA-GALACTOSIDASE A (A-GAL A) PEPTIDES AND FUNCTIONAL VARIANTS THEREOF AND ASSOCIATED METHODS OF TREATING FABRY DISEASE

 #19
20240336949
2024-10-10

DIGITAL MICROBIOLOGY

 #20
20240327475
2024-10-03

ICAM-1 targeted fusion enzymes

 #21
20240301380
2024-09-12

Compositions and Methods for Treating Fabry Disease

 #22
20240279187
2024-08-22

COMPOUNDS, DEVICES, AND USES THEREOF

 #23
20240240195
2024-07-18

COMPOSITIONS AND METHODS FOR INCREASING EXTRACTIBILITY OF SOLIDS FROM COFFEE BEANS

 #24
20240218342
2024-07-04

SITE-SPECIFIC GLYCAN REMODELING OF LYSOSOMAL ENZYMES AND APPLICATIONS THEREOF

 #25
20240209336
2024-06-27

GENETICALLY MODIFIED HUMAN CELL LINES AND USES THEREOF

 #26
20240196872
2024-06-20

DOUBLE KNOCKOUT (GT/CMAH-KO) PIGS, ORGANS AND TISSUES

 #27
20240175054
2024-05-30

COMPOSITION AND METHODS FOR THE TREATMENT OF FABRY DISEASE

 #28
20240035056
2024-02-01

Method and special complex enzyme for hydrolyzing galactomannan (GM) to prepare small-molecule GM and galactomannan oligosaccharide (GMOS)

 #29
20240025943
2024-01-25

METHOD FOR OBTAINING MATERIAL FROM PLANT CELL SURFACES

 #30
20240018498
2024-01-18

CODON OPTIMIZED GLA GENES AND USES THEREOF

 #31
20240009281
2024-01-11

MRNA THERAPY FOR POMPE DISEASE

 #32
20230416715
2023-12-28

LYSOSOMAL ENZYMES MODIFIED BY CELL BASED GLYCOENGINEERING

 #33
20230416714
2023-12-28

USE OF THERAPEUTIC ENZYME FUSION PROTEIN IN PREVENTION AND TREATMENT OF NEUROPATHY CAUSED BY OR ACCOMPANIED BY FABRY DISEASE

 #34
20230365955
2023-11-16

COMPOSITIONS AND METHODS FOR TREATMENT OF FABRY DISEASE

 #35
20230365954
2023-11-16

AFFINITY PURIFICATION OF GLYCOSIDE-CLEAVING ENZYMES

 #36
20230340507
2023-10-26

Yeast promotors for protein expression

 #37
20230332112
2023-10-19

Novel In Vitro and In Vivo Enrichment Strategy Targeting Lymphocytes Derived from Vector Transduced HSCS for Therapy of Disorders

 #38
20230330262
2023-10-19

Lipid nanoparticle compositions and methods for mRNA delivery

 #39
20230323371
2023-10-12

POLYNUCLEOTIDES ENCODING ALPHA-GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE

 #40
20230303993
2023-09-28

FOOD SUPPLEMENT COMPOSITION TO AID IN DIGESTION OF FRUCTAN, MANNITOL, AND SORBITOL

 #41
20230293723
2023-09-21

LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY

 #42
20230285593
2023-09-14

Lipid nanoparticle compositions and methods for MRNA delivery

 #43
20230285592
2023-09-14

Lipid nanoparticle compositions and methods for MRNA delivery

 #44
20230203465
2023-06-29

Highly Potent Acid Alpha-Glucosidase With Enhanced Carbohydrates

 #45
20230190964
2023-06-22

Codon optimized GLA genes and uses thereof

 #46
20230180791
2023-06-15

ANIMAL FEED COMPOSITIONS

 #47
20230158123
2023-05-25

Recombinant Alpha-Galactosidase A For Treatment Of Fabry Disease

 #48
20230074255
2023-03-09

STABILIZED ALPHA-GALACTOSIDASE AND USES THEREOF

 #49
20220380791
2022-12-01

Glycosylated lysosomal proteins, method of production and uses

 #50
20220378939
2022-12-01

Lipid nanoparticle compositions and methods for mRNA delivery

 #51
20220362406
2022-11-17

LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY

 #52
20220356458
2022-11-10

Human alpha-galactosidase variants

 #53
20220348896
2022-11-03

Improved Alpha-Galactosidase Protein for Enzyme Replacement Therapy (ERT) and Methods of Use

 #54
20220275409
2022-09-01

A GENETICALLY MODIFIED FUNGUS AND METHODS AND USES RELATED THERETO

 #55
20220273819
2022-09-01

METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY DISEASE

 #56
20220204573
2022-06-30

ICAM-1 targeted fusion enzymes

 #57
20220195484
2022-06-23

Digital microbiology

 #58
20220162578
2022-05-26

Highly potent acid alpha-glucosidase with enhanced carbohydrates

 #59
20220127591
2022-04-28

Modified recombinant lysosomal alpha-galactosidase A and aspartylglucoaminidase having low mannose-6-phosphate and high sialic acid

 #60
20220112475
2022-04-14

NOVEL ALPHA-GALACTOSIDASE A DERIVATIVES

 #61
20220111072
2022-04-14

Lipid nanoparticle compositions and methods for mRNA delivery

 #62
20220111071
2022-04-14

LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY

 #63
20220111070
2022-04-14

Lipid nanoparticle compositions and methods for MRNA delivery

 #64
20220105201
2022-04-07

Lipid nanoparticle compositions and methods for mRNA delivery

 #65
20220090129
2022-03-24

RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR FOR GENE DELIVERY

 #66
20220064617
2022-03-03

Recombinant Glycoproteins and Uses Thereof

 #67
20220054602
2022-02-24

mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES

 #68
20220040330
2022-02-10

Lipid nanoparticle compositions and methods for mRNA delivery

 #69
20220016263
2022-01-20

FABRY DISEASE GENE THERAPY

 #70
20210401951
2021-12-30

MRNA therapy for pompe disease

 #71
20210332341
2021-10-28

Codon optimized GLA genes and uses thereof

 #72
20210300755
2021-09-30

Lipid nanoparticle compositions and methods for mRNA delivery

 #73
20210292726
2021-09-23

Polypeptides having alpha-galactosidase activity and polynucleotides encoding same

 #74
20210284984
2021-09-16

Microorganism capable of displaying α-galactosidase on surface layer thereof, and use thereof

 #75
20210269787
2021-09-02

HUMAN ALPHA-GALACTOSIDASE VARIANTS

 #76
20210261935
2021-08-26

Highly potent acid alpha-glucosidase with enhanced carbohydrates

 #77
20210244804
2021-08-12

Human alpha-galactosidase variants

 #78
20210222185
2021-07-22

COMPOSITIONS AND METHODS FOR INCREASING EXTRACTABILITY OF SOLIDS FROM COFFEE BEANS

 #79
20210147495
2021-05-20

ICAM-1 targeted fusion enzymes

 #80
20210076647
2021-03-18

Double knockout (GT/CMAH-KO) pigs, organs and tissues

 #81
20210060177
2021-03-04

Lipid nanoparticle compositions and methods for mRNA delivery

 #82
20210040465
2021-02-11

Affinity purification of glycosidase-cleaving enzymes

 #83
20210032643
2021-02-04

Yeast promotors for protein expression

 #84
20210017500
2021-01-21

ANIMAL CELL STRAIN AND METHOD FOR USE IN PRODUCING GLYCOPROTEIN, GLYCOPROTEIN AND USE THEREOF

 #85
20210009984
2021-01-14

THERAPEUTIC ENZYME FUSION PROTEIN HAVING A NOVEL STRUCTURE AND USE THEREOF

 #86
20200405826
2020-12-31

Human alpha-galactosidase variants

 #87
20200399669
2020-12-24

Polypeptides Having Alpha-Galactosidase Activity and Polynucleotides Encoding Same

 #88
20200399668
2020-12-24

Polypeptides Having Alpha-Galactosidase Activity and Polynucleotides Encoding Same

 #89
20200369718
2020-11-26

Sterile chromatography and manufacturing processes

 #90
20200360490
2020-11-19

Human alpha-galactosidase variants

 #91
20200360489
2020-11-19

Human alpha-galactosidase variants

 #92
20200338214
2020-10-29

Lipid nanoparticle compositions and methods for mRNA delivery

 #93
20200317726
2020-10-08

Integrated continuous manufacturing of therapeutic protein drug substances

 #94
20200239911
2020-07-30

METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY DISEASE

 #95
20200199563
2020-06-25

Human alpha-galactosidase variants

 #96
20200181582
2020-06-11

and enrichment strategy targeting lymphocytes derived from vector transduced HSCs for therapy of disorders

 #97
20200149052
2020-05-14

Polynucleotides encoding α-galactosidase A for the treatment of Fabry disease

 #98
20200147184
2020-05-14

Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof

 #99
20200138933
2020-05-07

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #100
20200131493
2020-04-30

Elution of biomolecules from multi-modal resins using MES and MOPS as mobile phase modifiers

 #101
20200115698
2020-04-16

PHARMACEUTICAL COMBINATION FOR TREATMENT OF FABRY DISEASE AND USE THEREOF

 #102
20200085973
2020-03-19

LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY

 #103
20200039943
2020-02-06

Compounds, devices, and uses thereof

 #104
20190358302
2019-11-28

Recombinant α-galactosidase A for treatment of Fabry disease

 #105
20190321489
2019-10-24

Lipid nanoparticle compositions and methods for mRNA delivery

 #106
20190289880
2019-09-26

Animal feed additives

 #107
20190276812
2019-09-12

Highly potent acid alpha-glucosidase with enhanced carbohydrates

 #108
20190256832
2019-08-22

Stabilized alpha-galactosidase and uses thereof

 #109
20190203239
2019-07-04

Thermophilic and thermoacidophilic biopolymer-degrading genes and enzymes from and related organisms, methods

 #110
20190192689
2019-06-27

Lipid nanoparticle compositions and methods for mRNA delivery

 #111
20190175761
2019-06-13

Lipid nanoparticle compositions and methods for mRNA delivery

 #112
20190151431
2019-05-23

IMMUNOGENIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MENINGOCOCCAL DISEASE

 #113
20190144902
2019-05-16

Polypeptides having alpha-galactosidase activity and polynucleotides encoding same

 #114
20190134164
2019-05-09

MRNA therapy for Pompe disease

 #115
20190106691
2019-04-11

Glycosylation independent proteins

 #116
20190083639
2019-03-21

Scavenger receptor uptake for Fabry disease enzyme replacement therapy

 #117
20190078097
2019-03-14

Polynucleotide Constructs For In Vitro and In Vivo Expression

 #118
20190054154
2019-02-21

Targeting of glycoprotein therapeutics

 #119
20190046657
2019-02-14

Conjugate of therapeutic enzymes

 #120
20190032105
2019-01-31

Digital microbiology

 #121
20190002890
2019-01-03

Polynucleotides encoding alpha-galactosidase A for the treatment of Fabry disease

 #122
20190000933
2019-01-03

Polynucleotides encoding α-galactosidase A for the treatment of Fabry disease

 #123
20180362947
2018-12-20

Methods of purifying recombinant alpha-Galactosidase A

 #124
20180354986
2018-12-13

STERILE CHROMATOGRAPHY AND MANUFACTURING PROCESSES

 #125
20180332832
2018-11-22

Porcine animals lacking expression of functional alpha 1, 3 galactosyltransferase

 #126
20180327758
2018-11-15

RECOMBINANT MICROALGAE INCLUDING KETO-ACYL ACP SYNTHASE

 #127
20180236047
2018-08-23

MRNA for use in treatment of human genetic diseases

 #128
20180201964
2018-07-19

Thermophilic and thermoacidophilic biopolymer-degrading genes and enzymes from and related organisms, methods

 #129
20180185503
2018-07-05

Chemical crosslinkers

 #130
20180185495
2018-07-05

THERAPEUTIC COMPOSITIONS OF ALPHA-L-IDURONIDASE, IDURONATE-2-SULFATASE, AND ALPHA-GALACTOSIDASE A AND METHODS OF USE THEREOF

 #131
20180153146
2018-06-07

Double knockout (GT/CMAH-KO) pigs, organs and tissues

 #132
20180148703
2018-05-31

Stabilized α-galactosidase and uses thereof

 #133
20180117181
2018-05-03

Methods and compositions for the treatment of Fabry disease

 #134
20180110878
2018-04-26

Fabry disease gene therapy

 #135
20180085436
2018-03-29

Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof

 #136
20180016648
2018-01-18

Glycosylated lysosomal proteins, method of production and uses

 #137
20180016564
2018-01-18

Method for production of recombinant human alpha-galactosidase A from material containing contaminant host cell proteins by chromatography

 #138
20170360901
2017-12-21

α-galactosidase A and 1-deoxygalactonojirimycin co-formulation

 #139
20170360900
2017-12-21

HUMAN ALPHA-GALACTOSIDASE VARIANTS

 #140
20170298335
2017-10-19

Highly potent acid alpha-glucosidase with enhanced carbohydrates

 #141
20170239371
2017-08-24

Lipid nanoparticle compositions and methods for MRNA delivery

 #142
20170226493
2017-08-10

Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose

 #143
20170218012
2017-08-03

Integrated continuous manufacturing of therapeutic protein drug substances

 #144
20170173140
2017-06-22

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #145
20170051267
2017-02-23

NOVEL ALPHA-GALACTOSIDASE A DERIVATIVES

 #146
20170042979
2017-02-16

TARGETING OF GLYCOPROTEIN THERAPEUTICS

 #147
20160324940
2016-11-10

MRNA therapy for pompe disease

 #148
20160298158
2016-10-13

Thermophilic and thermoacidophilic biopolymer-degrading genes and enzymes from and related organisms, methods

 #149
20160265012
2016-09-15

Agarooligosaccharide hydrolase and method for producing 3,6-anhydro-L-galactose and galactose from agarose by using same

 #150
20160264953
2016-09-15

Recombinant glycoproteins and uses thereof

 #151
20160208006
2016-07-21

Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU

 #152
20160186191
2016-06-30

Tailored oils produced from recombinant heterotrophic microorganisms

 #153
20160183561
2016-06-30

Polypeptides having a-L-Galactosidase Activity and Polynucleotides Encoding Same

 #154
20160129126
2016-05-12

Chemical crosslinkers

 #155
20160101160
2016-04-14

mRNA for use in treatment of human genetic diseases

 #156
20160053247
2016-02-25

Stabilized alpha-galactosidase and uses thereof

 #157
20160040146
2016-02-11

Purification of recombinant alpha galactosidase A

 #158
20160024538
2016-01-28

Recombinant microalgae including keto-acyl ACP synthase

 #159
20160024511
2016-01-28

Yeast promoters for protein expression

 #160
20150335724
2015-11-26

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #161
20150275250
2015-10-01

Thermophilic and thermoacidophilic biopolymer degrading genes and enzymes from and related organisms, methods

 #162
20150275195
2015-10-01

ELUTION OF BIOMOLECULES FROM MULTI-MODAL RESINS USING MES AND MOPS AS MOBILE PHASE MODIFIERS

 #163
20150264900
2015-09-24

Double knockout (GT/CMAH-KO) pigs, organs and tissues

 #164
20150225705
2015-08-13

Expression of enzymes in yeast for lignocellulose derived oligomer CBP

 #165
20150216960
2015-08-06

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #166
20150210992
2015-07-30

Method for production of recombinant human alpha-galactosidase A

 #167
20150203532
2015-07-23

STERILE CHROMATOGRAPHY AND MANUFACTURING PROCESSES

 #168
20150203529
2015-07-23

Sterile chromatography and manufacturing processes

 #169
20150202270
2015-07-23

Methods for introducing mannose 6 phosphate and other oligosaccharides onto glycoproteins and applications thereof

 #170
20150183821
2015-07-02

Integrated continuous manufacturing of therapeutic protein drug substances

 #171
20150174214
2015-06-25

α-galactosidase A and 1-deoxygalactonojirimycin co-formulation

 #172
20150079066
2015-03-19

Means and methods for generating improved proteins

 #173
20150004217
2015-01-01

mRNA for use in treatment of human genetic diseases

 #174
20140323356
2014-10-30

Glycosidase enzymes

 #175
20140294939
2014-10-02

Pulmonary delivery of mRNA

 #176
20140294938
2014-10-02

MRNA therapy for Fabry disease

 #177
20140271577
2014-09-18

Plant cell culture expressing human lysosomal proteins and uses thereof

 #178
20140255994
2014-09-11

Integrated continuous manufacturing of therapeutic protein drug substances

 #179
20140220553
2014-08-07

Enzymatic Conversion of Blood Group A, B, and AB Red Blood Cells Using alpha-N-Acetylgalactosaminidases and alpha-Galactosidases with Unique Substrate Specificities and Kinetic Properties

 #180
20140206718
2014-07-24

Method of enhancing lysosomal α-galactosidase A

 #181
20140171493
2014-06-19

Highly functional enzyme having alpha-galactosidase activity

 #182
20140154726
2014-06-05

Perfusion Culturing Methods and Uses Thereof

 #183
20140051725
2014-02-20

Method for increasing the activity of lysosomal enzymes

 #184
20140050666
2014-02-20

Scavenger receptor uptake for fabry disease enzyme replacement therapy

 #185
20140044699
2014-02-13

Polynucleotides encoding proteins having acquired α-galactosidase activity

 #186
20140004588
2014-01-02

Methods and compositions for degrading pectin

 #187
20130316406
2013-11-28

Thermophilic and thermoacidophilic biopolymer-degrading genes and enzymes from and related organisms, methods

 #188
20130295065
2013-11-07

Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells

 #189
20130195835
2013-08-01

Microorganisms genetically engineered to have modified N-glycosylation activity

 #190
20130190253
2013-07-25

Microorganisms genetically engineered to have modified N-glycosylation activity

 #191
20130177545
2013-07-11

Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof

 #192
20130064805
2013-03-14

Highly functional enzyme having α-galactosidase activity

 #193
20130004646
2013-01-03

Compositions Comprising Tailored Oils

 #194
20120329091
2012-12-27

Recombinant protein production in heterologous systems

 #195
20120328592
2012-12-27

Stabilized alpha-galactosidase and uses thereof

 #196
20120324784
2012-12-27

Tailored oils produced from recombinant heterotrophic microorganisms

 #197
20120308595
2012-12-06

Novel Immunogenic Compositions For The Prevention And Treatment of Meningococcal Disease

 #198
20120301496
2012-11-29

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #199
20120294880
2012-11-22

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #200
20120282231
2012-11-08

Human lysosomal proteins from plant cell culture

 #201
20120276078
2012-11-01

Glycosidase enzymes

 #202
20120255047
2012-10-04

Porcine Animals Lacking Any Expression of Functional Alpha 1,3 Galactosyltransferase

 #203
20120252117
2012-10-04

OPTIMIZED MESSENGER RNA

 #204
20120202273
2012-08-09

comprising an α-galactosidase for removing immunodominant α-galactose monosaccharides from blood group B or AB reactive cells

 #205
20120201844
2012-08-09

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #206
20120142756
2012-06-07

mRNA for use in treatment of human genetic diseases

 #207
20120141507
2012-06-07

Targeting of glycoprotein therapeutics

 #208
20120141453
2012-06-07

Glycosidase Enzymes

 #209
20120129216
2012-05-24

Enzymatic antibody processing

 #210
20120094347
2012-04-19

METHODS AND COMPOSITIONS FOR DEGRADING PECTIN

 #211
20120034261
2012-02-09

NOVEL IMMUNOGENIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MENINGOCOCCAL DISEASE

 #212
20110294174
2011-12-01

Tailored oils produced from recombinant heterotrophic microorganisms

 #213
20110293785
2011-12-01

FOOD COMPOSITIONS COMPRISING TAILORED OILS

 #214
20110280856
2011-11-17

TREATMENT OF ALPHA-GALACTOSIDASE A DEFICIENCY

 #215
20110250181
2011-10-13

Human lysosomal proteins from plant cell culture

 #216
20110207676
2011-08-25

Microorganisms genetically engineered to have modified N-glycosylation activity

 #217
20110201540
2011-08-18

Glycosylation of molecules

 #218
20110182868
2011-07-28

Human lysosomal proteins from plant cell culture

 #219
20110171198
2011-07-14

Highly functional enzyme having α-galactosidase activity

 #220
20110136175
2011-06-09

Thermophilic and thermoacidophilic biopolymer-degrading genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods

 #221
20110076765
2011-03-31

Method for increasing the activity of lysosomal enzymes

 #222
20110076299
2011-03-31

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #223
20110059487
2011-03-10

ENGINEERED MICROORGANISMS AND METHODS OF USE

 #224
20110045569
2011-02-24

α-galactosidases for removing immunodominant α-galactose monosaccharides from blood group B or AB reactive cells

 #225
20110027241
2011-02-03

Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells

 #226
20110027237
2011-02-03

Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells

 #227
20110014170
2011-01-20

Methods of preparing tissues for xenotransplantation using α-galactosidases

 #228
20100311845
2010-12-09

Glycosidase enzymes

 #229
20100291059
2010-11-18

Proteins having acquired A-galactosidase activity

 #230
20100255111
2010-10-07

Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells

 #231
20100173385
2010-07-08

Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof

 #232
20100166728
2010-07-01

Highly functional enzyme having α-galactosidase activity

 #233
20100137229
2010-06-03

Method of enhancing lysosomal α-galactosidase A

 #234
20100137184
2010-06-03

Cleaning Compositions Comprising Alpha-Galactosidase

 #235
20100068183
2010-03-18

Methods of treating lysosomal storage related diseases by gene therapy

 #236
20100062526
2010-03-11

OPTIMIZED MESSENGER RNA

 #237
20100041151
2010-02-18

Compositions and methods for treating lysosomal storage disease

 #238
20090257989
2009-10-15

Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells

 #239
20090238802
2009-09-24

Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells

 #240
20090220474
2009-09-03

Method of preparing non-human tissues for xenotransplantation using α-galactosidase

 #241
20090208477
2009-08-20

Production of high mannose proteins in plant culture and therapeutic uses thereof

 #242
20090148906
2009-06-11

OPTIMIZED MESSENGER RNA

 #243
20090142326
2009-06-04

Glycosidase enzymes

 #244
20090069232
2009-03-12

and HAC1 nucleic acids

 #245
20090042283
2009-02-12

OPTIMIZED MESSENGER RNA

 #246
20090017533
2009-01-15

OPTIMIZED MESSENGER RNA

 #247
20080279985
2008-11-13

ENZYMES HAVING GLYCOSIDASE ACTIVITY AND METHODS OF USE THEREOF

 #248
20080226658
2008-09-18

Targeting of glycoprotein therapeutics

 #249
20080160584
2008-07-03

α-agarase and process for producing the same

 #250
20080076174
2008-03-27

OPTIMIZED MESSENGER RNA

 #251
20080038232
2008-02-14

Human lysosomal proteins from plant cell culture

 #252
20070238693
2007-10-11

Genetic modification of the lung as a portal for gene delivery

 #253
20070166804
2007-07-19

α-agarase and process for producing the same

 #254
20070148752
2007-06-28

Sulfated fucogalactan digesting enzyme gene

 #255
20070116744
2007-05-24

Pectate lyases

 #256
20070036883
2007-02-15

Plant-derived alkaline alpha-galactosidase

 #257
20070021381
2007-01-25

Method for increasing the activity of acid-β-galactosidase

 #258
20060257413
2006-11-16

Immunogenic compositions for the prevention and treatment of meningococcal disease

 #259
20060234355
2006-10-19

α-Agarase and process for producing the same

 #260
20060228348
2006-10-12

Targeting of glycoprotein therapeutics

 #261
20060100241
2006-05-11

Method for enhancing mutant protein activity

 #262
20060084163
2006-04-20

Plant-derived alkaline alpha-galactosidase

 #263
20060063733
2006-03-23

Methods of reducing an immune response

 #264
20060057114
2006-03-16

Methods of treating lysosomal storage related diseases by gene therapy

 #265
20060031965
2006-02-09

In- seed expression of lysosomal enzymes

 #266
20050221364
2005-10-06

Enzymes having alpha-galactosidase activity and methods of use thereof

 #267
20050208655
2005-09-22

Blood cells having modified antigenicity

 #268
20050208520
2005-09-22

Polynucleotide sequences encoding alkaline α-galactosidases and methods of using same

 #269
20050202425
2005-09-15

Sulfated fucogalactan digesting enzyme gene

 #270
20050136488
2005-06-23

Cellular membrane protein assay

 #271
20050125859
2005-06-09

Production of lysosomal enzymes in plants by transient expression

 #272
20050113415
2005-05-26

Method for enhancing mutant enzyme activities in Gaucher disease

 #273
20050059127
2005-03-17

Method for recovering proteins from the interstitial fluid of plant tissues

 #274
20050058634
2005-03-17

Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof

 #275
20050048637
2005-03-03

Methods for sterilizing preparations of glycosidases

 #276
15716621
2020-02-25

Recombinant microorganisms for conversion of oligosaccharides into functional sweeteners